Literature DB >> 21383047

The role of the ubiquitin proteasome system in Alzheimer's disease.

Beat M Riederer1, Geneviève Leuba, André Vernay, Irène M Riederer.   

Abstract

Today, Alzheimer's disease (AD) is one of the most important age-related neurodegenerative diseases, but its etiology remains still unknown. Since the discovery that the hallmark structures of this disease i.e. the formation of amyloid fibers could be the product of ubiquitin-mediated protein degradation defects, it has become clear that the ubiquitin-proteasome system (UPS), usually essential for protein repair, turnover and degradation, is perturbed in this disease. Different aspects of normal and pathological aging are discussed with respect to protein repair and degradation via the UPS, as well as consequences of a deficit in the UPS in AD. Selective protein oxidation may cause protein damage, or protein mutations may induce a dysfunction of the proteasome. Such events eventually lead to activation of cell death pathways and to an aberrant aggregation or incorporation of ubiquitinated proteins into hallmark structures. Aggresome formation is also observed in other neurodegenerative diseases, suggesting that an activation of similar mechanisms must occur in neurodegeneration as a basic phenomenon. It is essential to discuss therapeutic ways to investigate the UPS dysfunction in the human brain and to identify specific targets to hold or stop cell decay.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383047     DOI: 10.1258/ebm.2010.010327

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  49 in total

1.  A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.

Authors:  Karine Enesa; Herwig P Moll; Le Luong; Christiane Ferran; Paul C Evans
Journal:  FASEB J       Date:  2015-02-09       Impact factor: 5.191

2.  Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Antonella Tramutola; Alessandra Giorgi; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2014-03-25       Impact factor: 7.376

3.  Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and Neurodegeneration.

Authors:  Dolores Del Prete; Richard C Rice; Anjali M Rajadhyaksha; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

4.  Expression of p97/VCP and ubiquitin during postnatal development of the degenerating rat retina.

Authors:  Huseyin Ortak; Sevil Cayli; Ufuk Tas; Seda Ocakli; Erkan Söğüt; Helin Deniz Demir
Journal:  J Mol Histol       Date:  2011-11-19       Impact factor: 2.611

5.  Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments.

Authors:  Haizhi Wang; Nianli Sang; Can Zhang; Ramesh Raghupathi; Rudolph E Tanzi; Aleister Saunders
Journal:  Biochemistry       Date:  2015-04-28       Impact factor: 3.162

6.  RIPK1 mediates a disease-associated microglial response in Alzheimer's disease.

Authors:  Dimitry Ofengeim; Sonia Mazzitelli; Yasushi Ito; Judy Park DeWitt; Lauren Mifflin; Chengyu Zou; Sudeshna Das; Xian Adiconis; Hongbo Chen; Hong Zhu; Michelle A Kelliher; Joshua Z Levin; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

7.  The deubiquitylase USP10 regulates integrin β1 and β5 and fibrotic wound healing.

Authors:  Stephanie R Gillespie; Liana J Tedesco; Lingyan Wang; Audrey M Bernstein
Journal:  J Cell Sci       Date:  2017-08-29       Impact factor: 5.285

Review 8.  Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways.

Authors:  Wagner Carbolin Martins; Carla Inês Tasca; Helena Cimarosti
Journal:  Neurochem Res       Date:  2015-07-31       Impact factor: 3.996

9.  Betaine protects against rotenone-induced neurotoxicity in PC12 cells.

Authors:  A-Rang Im; Young-Hwa Kim; Md Romij Uddin; Sungwook Chae; Hye Won Lee; Yun Hee Kim; Yeong Shik Kim; Mi-Young Lee
Journal:  Cell Mol Neurobiol       Date:  2013-04-20       Impact factor: 5.046

10.  Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.

Authors:  Fabio Di Domenico; Raffaella Coccia; Annalisa Cocciolo; M Paul Murphy; Giovanna Cenini; Elizabeth Head; D Allan Butterfield; Alessandra Giorgi; Maria Eugenia Schinina; Cesare Mancuso; Chiara Cini; Marzia Perluigi
Journal:  Biochim Biophys Acta       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.